MOLBIO logo

Molbio Diagnostics Limited

MOLBIO · NSE · Healthcare

₹1,503.00+₹108.907.81%Prev. close ₹1,394.10
At close: 13 Nov 2026, 3:30 PM India time · NSE
Market cap
₹17,226 Cr
Trailing P/E
117.15
Forward P/E
—
Open
₹1,412.60
Day range
₹1,394.10 – ₹1,545.00
52W range
₹926.35 – ₹1,686.80
EPS (TTM)
₹12.83
Dividend yield
0.00%
Volume
23.03 L
P/B
12.70
ROE
14.8%
Debt / equity
0.03

News

Financials

Earnings

Valuation

Ownership

Business

Technicals

Your research

Molbio Diagnostics Limited (MOLBIO): company summary

Molbio Diagnostics Limited (MOLBIO) is a small-cap Healthcare company valued at ₹17,226 crore operating in Medical Equipment & Supplies on the NSE and BSE.

Molbio Diagnostics Limited (MOLBIO) is a small-cap Healthcare company valued at ₹17,226 crore operating in Medical Equipment & Supplies on the NSE and BSE.

Recent price move
Molbio Diagnostics Limited last traded at ₹1,503, sharply up 7.81% on the day.
Financial performance
Revenue has been growing strongly at 58.9% a year over three years; profit grew 108.5% a year, ahead of revenue — margins are expanding. Return on equity is 14.8%.
Valuation multiples
The stock trades at 117.2 times earnings, a premium to the Healthcare median of 32.1, 12.70 times book value.

Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

MOLBIOFree with a DocStoX account

Molbio Diagnostics Limited peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.